Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02205047 |
Title | Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma (INNOVATION) |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | European Organisation for Research and Treatment of Cancer - EORTC |
Indications | |
Therapies |
Cisplatin + Fluorouracil + Pertuzumab + Trastuzumab Cisplatin + Fluorouracil + Trastuzumab |
Age Groups: | senior | adult |
Covered Countries | ITA | FRA | ESP | DEU | BEL |